The dynamic evaluation of clinical symptoms and ultrasound signs in patients with uterine fibroids undergone the antiprogestogens therapy

Full Text


A study involving 20 women with uterine fibroids. Women age 45 years. 10 women receiving progestogen (mifepristone) for 3 months at a dosage of 50ml with 2 days of the menstrual cycle. All women were examined at baseline and after 3 months. The effective use of mifepristone.

About the authors

T A Pugacheva



  1. Гинекология - национальное руководство под ред. В.И. Кулакова, Г.М. Савельевой, И.Б. Манухина, 2009.
  2. Бебнева Т. Н., В. Н. Прилепская. «Фарматека» № 15(110), 2005.
  3. Савицкий Г.А., Савицкий А.Г. Миома матки: проблемы патогенеза и патогенетической терапии. - СПб. - 2000.
  4. Савельева Г.М., Краснова И.А., Бреусенко В.Г. Современные подходы к ведению больных с миомой матки //Международный медицинский журнал. - 2001. - № 4. - Т. 7. - С. 22-28.



Abstract: 48


Article Metrics

Metrics Loading ...



  • There are currently no refbacks.

Copyright (c) 2011 Pugacheva T.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies